Sunday, January 15, 2017 12:01 PM

CVS TAKES ON MYLAN’S EPIPEN WITH MUCH CHEAPER VERSION OF AN ALTERNATIVE

Drugstore chain CVS Health Corp said Thursday it is now offering a low-cost treatment for life-threatening allergies, after an outcry about the high cost of the best-selling product in the category, Mylan Inc.s EpiPen.

See also: Mylan CEO Heather Bresch says keeping drug price hikes below 10% isnt the answer[1]

CVS CVS, -0.75%[2] said it is selling the authorized generic for Adrenaclick, an alternative to the EpiPen, that is made by Impax Laboratories Inc. IPXL, +0.78%[3] priced at $109.99 for a two-pack.

That compares with the $649.99 cash price of an EpiPen and the $339.99 being charged for its authorized generic. Adrenaclick is an epinephrine auto-injector that was approved by the U.S. Food and Drug Administration ...

News source: Market Watch

See also: Steven Enrich